TD Cowen lowered the firm’s price target on Tempus AI (TEM) to $76 from $88 and keeps a Hold rating on the shares. The firm adjusted targets in the diagnostics group as part of a Q4 preview. It expects solid results and 2026 outlooks for the sector, saying strong fundamentals remain.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TEM:
- TEM, KDK, PSNL: Cathie Wood Loads Up on AI Health Tech, Trims SHOP & ROKU
- Cathie Wood’s ARK Funds Had ‘One Heck of a Year’ — What’s Next for 2026?
- Tempus AI price target lowered to $80 from $95 at Canaccord
- Balanced Outlook on Tempus AI: Evaluating Data Business Expansion and Personalized Medicine Potential
- Tempus AI price target lowered to $80 from $90 at BofA